|
Related Companies
|
[]
|
||||||||
|
Related Funds
|
[]
|
||||||||
|
|
|||||||||
|
English
|
|||||||||
|
oda_ForwardLookingEvaluationsAbstract|
|
|
||||||||
|
oda_UpdateAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_CorrectionAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_DateOfThePreviousNotificationAboutTheSameSubject|
|
|
-
|
|||||||
|
oda_DelayedAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_AnnouncementContentSection|
|
|
||||||||
|
oda_ExplanationSection|
|
|
||||||||
|
oda_ExplanationTextBlock|
|
Our guidance for 2024 including the TAS29 impact is as follows:
- Revenue growth (excluding IFRIC 12) to be 11-13%
- EBITDA margn to be 36-38%
- CAPEX intensity to be 27-28%
Note: We assumed an inflation trajectory leading annual CPI to 42% by the end of 2024.
2024 guidance expectations represent approximate values.
|
||||||||